N-[[(5S)-2-oxo-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-1,3-oxazolidin-5-yl]methyl]acetamide | 444588-27-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: N-[[(5S)-2-oxo-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-1,3-oxazolidin-5-yl]methyl]acetamide
• CAS: 444588-27-6
• 化学式: C₁₆H₂₁N₃O₃
• 分子量: 303.361
• InChiKey: DFOCRULDBLHTOL-HNNXBMFYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  70.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[[(5S)-2-oxo-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-1,3-oxazolidin-5-yl]methyl]acetamide 在 potassium carbonate 、 三乙胺 作用下， 以 甲醇 为溶剂， 生成 N-{[(5S)-3-(3-glycoloyl-1,2,4,5-tetrahydro-1H-3-benzazepin-7-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
  参考文献：
  名称：

  Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials

  摘要：

  Novel benzazepine oxazolidinone antibacterials were synthesized and evaluated against clinically relevant susceptible and resistant organisms. The effect of ring nitrogen position and N-substitution on antibacterial activity is examined. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.07.017
• 作为产物：
  描述：

  Benzyl 7-(phenylmethoxycarbonylamino)-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate 在 甲醇 、 lithium tert-amoxide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 N-[[(5S)-2-oxo-3-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)-1,3-oxazolidin-5-yl]methyl]acetamide
  参考文献：
  名称：

  Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials

  摘要：

  Novel benzazepine oxazolidinone antibacterials were synthesized and evaluated against clinically relevant susceptible and resistant organisms. The effect of ring nitrogen position and N-substitution on antibacterial activity is examined. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.07.017

文献信息

• [EN] OXAZOLIDINONE DERIVATIVES N-SUBSTITUTED BY A BICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS<br/>[FR] DERIVES D'OXAZOLIDINONE N-SUBSTITUES PAR UN NOYAU BICYCLIQUE, UTILISES COMME AGENTS ANTIBACTERIENS
  申请人：WARNER LAMBERT CO

  公开号：WO2004069244A1

  公开（公告）日：2004-08-19

  Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial agents. P is a bicyclic ring system as defined in claim 1.

  公式（I）的化合物及其制备方法已被披露。进一步披露了制备公式（I）生物活性化合物的方法，以及包含公式（I）化合物的药用可接受组合物的方法。本文披露的公式（I）化合物可用于各种应用，包括用作抗菌剂。P是如权利要求1所定义的双环环系统。
• Antibacterial agents
  申请人：Hagen Susan

  公开号：US20050070523A1

  公开（公告）日：2005-03-31

  Compounds of formula I and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula I as well as pharmaceutically acceptable compositions comprising compounds of formula I. Compounds of formula I as disclosed herein can be used in a variety of applications, including using the invention compounds to treat bacterial infections.

  本发明公开了化学式I的化合物及其制备方法。还公开了制备具有生物活性的化学式I化合物的方法，以及包含化学式I化合物的药学上可接受的组合物的制备方法。如本文所述的化学式I化合物可用于各种应用，包括使用发明化合物治疗细菌感染。
• OXAZOLIDINONE DERIVATIVES N-SUBSTITUTED BY A BICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS
  申请人：Warner-Lambert Company LLC

  公开号：EP1594494A1

  公开（公告）日：2005-11-16
• US7304050B2
  申请人：——

  公开号：US7304050B2

  公开（公告）日：2007-12-04
• Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials
  作者：Paul D. Johnson、Paul A. Aristoff、Gary E. Zurenko、Ronda D. Schaadt、Betty H. Yagi、Charles W. Ford、Judith C. Hamel、Douglas Stapert、Judy K. Moerman

  DOI：10.1016/j.bmcl.2003.07.017

  日期：2003.12

  Novel benzazepine oxazolidinone antibacterials were synthesized and evaluated against clinically relevant susceptible and resistant organisms. The effect of ring nitrogen position and N-substitution on antibacterial activity is examined. (C) 2003 Elsevier Ltd. All rights reserved.